公开(公告)号：US20210169854A1

公开(公告)日：2021-06-10

申请号：US17025853

申请日：2020-09-18

Applicant: NOVARTIS AG

Inventor： Mangesh Sadashiv Bordawekar ,  Stephanie Kay Dodd ,  Cornelius Stephan Harlacher ,  Jithin K John ,  Pravin Karmuse ,  Saran Kumar ,  Sangeetha Kumari ,  Vishnu Maremanda ,  Parthkumar Patel ,  Kanhaiyalal Patidar ,  Kapil Patil ,  Alan Edward Royce ,  Shaikh Mohsin Shaikh Hamid ,  Mauro Serratoni ,  Henricus Lambertus Gerardus Maria Tiemessen ,  Daya D Verma ,  Sunita Yadav

IPC: A61K31/4152 ,  A61K47/22 ,  A61K9/48 ,  G01N33/15

Abstract: Disclosed are novel pharmaceutical formulation containing 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid or a pharmaceutically acceptable salt thereof and processes for preparing the same.